Author:
Kashobwe Lackson,Sadrabadi Faezeh,Brunken Lars,Coelho Ana Carolina M.F.,Sandanger Torkjel M.,Braeuning Albert,Buhrke Thorsten,Öberg Mattias,Hamers Timo,Leonards Pim.E.G.
Reference106 articles.
1. Cardiometabolic health and per and polyfluoroalkyl substances in an Inuit population;Aker;Environ. Int,2023
2. Triglyceride metabolism in the liver;Alves-Bezerra;Compr. Physiol.,2017
3. Tipping the balance: hepatotoxicity and the 4 apical key events of hepatic steatosis;Angrish;Toxicol. Sci.,2016
4. ATSDR. (2021). Toxicological Profile for Perfluoroalkyls. (CS274127-A). https://www.atsdr.cdc.gov/ToxProfiles/tp200-p.pdf: Agency for Toxic Substances and Disease Registry (ATSDR); U.S. Department of Health and Human Services, Public Health ServiceATSDR Retrieved from https://www.atsdr.cdc.gov/ToxProfiles/tp200-p.pdf https://stacks.cdc.gov/view/cdc/59198/cdc_59198_DS1.pdf.
5. Exposure to low-dose perfluorooctanoic acid promotes hepatic steatosis and disrupts the hepatic transcriptome in mice;Attema;Mol. Metab.,2022